Sitagliptina/Metformina Kern Pharma

Sitagliptina/Metformina Kern Pharma combines two oral diabetes medications to help manage blood sugar levels. This combination therapy is designed for adults with type 2 diabetes, offering a convenient option for glycemic control. Suitable for patients already stabilized on individual components. Short-term use under medical supervision recommended.

Sitagliptina/Metformina Kern Pharma is used to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are not enough. Sitagliptin belongs to a class of drugs called DPP-4 inhibitors, which help regulate insulin production after meals. Metformin works by decreasing glucose production in the liver and improving the body’s response to insulin. This combination is typically prescribed when metformin alone does not provide adequate control.

This medication may help reduce high blood sugar levels, which can prevent symptoms like excessive thirst, frequent urination, and fatigue. Some users report improved energy levels and reduced sugar cravings over time. It does not cause immediate effects and works gradually with regular use. Blood sugar levels should be monitored as directed by a healthcare provider.

Keep this medication in a cool, dry place away from direct sunlight. Store at room temperature and ensure it is out of reach of children and pets. Do not use if the packaging is damaged or the tablets show signs of deterioration. Always follow the storage instructions provided with the product.

Alcohol may increase the risk of lactic acidosis, a rare but serious side effect associated with metformin. Certain medications, such as diuretics, steroids, or other diabetes drugs, may affect blood sugar levels when taken with this combination. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using.